Research from our group suggested that VEGFA stimulated OSCC and oral cancer- associated fibroblast cell migration and can be inhibited by a specific PI3 kinase and mTORC2 inhibitor. The gene discussed is VEGFA; the disease is lip and oral cavity carcinoma.